{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:49:14Z","timestamp":1792417754045,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00467-017-3763-8","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T09:44:54Z","timestamp":1501839894000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of renal function on antihypertensive drug safety and efficacy in children"],"prefix":"10.1007","volume":"33","author":[{"given":"Kevin M.","family":"Watt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Avant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"issue":"4","key":"3763_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","volume":"52","author":"JT Flynn","year":"2008","unstructured":"Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, Warady BA, Chronic Kidney Disease in Children Study Group (2008) Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension 52(4):631\u2013637","journal-title":"Hypertension"},{"issue":"10","key":"3763_CR2","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","volume":"14","author":"M Mitsnefes","year":"2003","unstructured":"Mitsnefes M, Ho PL, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14(10):2618\u20132622","journal-title":"J Am Soc Nephrol"},{"issue":"17","key":"3763_CR3","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhl","year":"2009","unstructured":"Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, M\u00f6ller K, Wigger M, Peruzzi L, Mehls O, Schaefer F, ESCAPE Trial Group (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361(17):1639\u20131650","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"3763_CR4","first-page":"S1","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","unstructured":"Kidney Disease Outcomes Quality Initiative (K\/DOQI) (2004) Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43 [Suppl]:S1\u2013S290","journal-title":"Am J Kidney Dis"},{"issue":"2 Suppl 4th Rep","key":"3763_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 [2 Suppl 4th Report]:555\u2013576","journal-title":"Pediatrics"},{"issue":"24","key":"3763_CR6","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.106.179568","volume":"114","author":"RE Kavey","year":"2006","unstructured":"Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J, American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research: endorsed by the American Academy of Pediatrics. Circulation 114(24):2710\u20132738","journal-title":"Circulation"},{"issue":"1","key":"3763_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1681\/ASN.2012121197","volume":"25","author":"JC Kupferman","year":"2014","unstructured":"Kupferman JC, Aronson Friedman L, Cox C, Flynn J, Furth S, Warady B, Mitsnefes M, CKiD Study Group (2014) BP control and left ventricular hypertrophy regression in children with CKD. J Am Soc Nephrol 25(1):167\u2013174","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3763_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2215\/CJN.08420811","volume":"8","author":"MC Matteucci","year":"2013","unstructured":"Matteucci MC, Chinali M, Rinelli G, W\u00fchl E, Zurowska A, Charbit M, Pongiglione G, Schaefer F, ESCAPE Trial Group (2013) Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol 8(2):203\u2013210","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4\u20135","key":"3763_CR9","first-page":"805","volume":"8","author":"C Loirat","year":"1986","unstructured":"Loirat C, Azancot A, Pillion G, Macher MA, Mouchet B, Gainet B, Mathieu H (1986) Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension. Clin Exp Hypertens A 8(4\u20135):805\u2013810","journal-title":"Clin Exp Hypertens A"},{"issue":"2","key":"3763_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0022-3476(88)80073-8","volume":"112","author":"H Trachtman","year":"1988","unstructured":"Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112(2):295\u2013298","journal-title":"J Pediatr"},{"issue":"9","key":"3763_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.amjhyper.2007.03.009","volume":"20","author":"T Seeman","year":"2007","unstructured":"Seeman T, Gilik J, Vondr\u00e1k K, Simkov\u00e1 E, Fl\u00f6gelov\u00e1 H, Hlad\u00edkov\u00e1 M, Janda J (2007) Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. Am J Hypertens 20(9):990\u2013996","journal-title":"Am J Hypertens"},{"issue":"6","key":"3763_CR12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1542\/peds.75.6.1091","volume":"75","author":"BL Mirkin","year":"1985","unstructured":"Mirkin BL, Newman TJ (1985) Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the international collaborative study group. Pediatrics 75(6):1091\u20131100","journal-title":"Pediatrics"},{"issue":"12","key":"3763_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0895-7061(02)03083-2","volume":"15","author":"LM Franscini","year":"2002","unstructured":"Franscini LM, Von Vigier RO, Pfister R, Casaulta-Aebischer C, Fossali E, Bianchetti MG (2002) Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases. Am J Hypertens 15(12):1057\u20131063","journal-title":"Am J Hypertens"},{"issue":"1","key":"3763_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cpt.127","volume":"98","author":"H Trachtman","year":"2015","unstructured":"Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee (2015) Pharmacokinetics, pharmacodynamics, and safety of Lisinopril in pediatric kidney transplant patients: implications for starting dose selection. Clin Pharmacol Ther 98(1):25\u201333","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3763_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1399-3046.2009.01216.x","volume":"14","author":"T Seeman","year":"2010","unstructured":"Seeman T, Dusek J, Vondrak K, Janda J (2010) Ramipril in the treatment of proteinuria in children after renal transplantation. Pediatr Transplant 14(2):283\u2013287","journal-title":"Pediatr Transplant"},{"issue":"6","key":"3763_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000266478","volume":"32","author":"T Seeman","year":"2009","unstructured":"Seeman T, Pohl M, Misselwitz J, John U (2009) Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with angiotensin-converting enzyme inhibitors. Kidney Blood Press Res 32(6):440\u2013444","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"3763_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00802.x","volume":"66","author":"E Wuhl","year":"2004","unstructured":"Wuhl E, Mehls O, Schaefer F, Group ET (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66(2):768\u2013776","journal-title":"Kidney Int"},{"issue":"10","key":"3763_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s00467-003-1190-5","volume":"18","author":"CT White","year":"2003","unstructured":"White CT, Macpherson CF, Hurley RM, Matsell DG (2003) Antiproteinuric effects of enalapril and losartan: a pilot study. Pediatr Nephrol 18(10):1038\u20131043","journal-title":"Pediatr Nephrol"},{"issue":"1\u20132","key":"3763_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s004670000422","volume":"15","author":"M Soergel","year":"2000","unstructured":"Soergel M, Verho M, Wuhl E, Gellermann J, Teichert L, Scharer K (2000) Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatr Nephrol 15(1\u20132):113\u2013118","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"3763_CR20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157\u20131167","journal-title":"N Engl J Med"},{"key":"3763_CR21","unstructured":"US Food and Drug Administration Modernization Act of 1997, Pub L No. 105\u2013115, 111 Stat 2296 (1997)"},{"key":"3763_CR22","unstructured":"Best Pharmaceuticals for Children Act. Pub L no. 107\u2013109, 115 Stat 1408 (2002). Available at: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/ucm049876.htm . 2002"},{"key":"3763_CR23","unstructured":"US Food and Drug Administration. New Pediatric Labeling Information Database. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/sda\/sdNavigation.cfm?sd=labelingdatabase"},{"issue":"9721","key":"3763_CR24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","volume":"375","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Sarafidis PA, Weir MR, Dahl\u00f6f B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA, ACCOMPLISH Trial investigators (2010) Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 375(9721):1173\u20131181","journal-title":"Lancet"},{"key":"3763_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"KDIGO CKD Work Group","year":"2013","unstructured":"KDIGO CKD Work Group (2013) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"3763_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0022-3476(84)80479-5","volume":"104","author":"GJ Schwartz","year":"1984","unstructured":"Schwartz GJ, Feld LG, Langford DJ (1984) A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104(6):849\u2013854","journal-title":"J Pediatr"},{"issue":"3","key":"3763_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","volume":"106","author":"GJ Schwartz","year":"1985","unstructured":"Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106(3):522\u2013526","journal-title":"J Pediatr"},{"issue":"3","key":"3763_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","volume":"81","author":"T Wyszy\u0144ska","year":"1992","unstructured":"Wyszy\u0144ska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P (1992) A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 81(3):244\u2013246","journal-title":"Acta Paediatr"},{"issue":"3","key":"3763_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27(3):363\u2013373","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"3763_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrneph.2011.137","volume":"7","author":"L Rees","year":"2011","unstructured":"Rees L, Mak RH (2011) Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol 7(11):615\u2013623","journal-title":"Nat Rev Nephrol"},{"issue":"5912","key":"3763_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/bmj.2.5912.189","volume":"2","author":"PR Betts","year":"1974","unstructured":"Betts PR, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2(5912):189\u2013193","journal-title":"Br Med J"},{"issue":"1","key":"3763_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semnephrol.2009.10.003","volume":"30","author":"ML Minnick","year":"2010","unstructured":"Minnick ML, Boynton S, Ndirangu J, Furth S (2010) Sex, race, and socioeconomic disparities in kidney disease in children. Semin Nephrol 30(1):26\u201332","journal-title":"Semin Nephrol"},{"issue":"11","key":"3763_CR33","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","volume":"14","author":"CY Hsu","year":"2003","unstructured":"Hsu CY, Lin F, Vittinghoff E, Shlipak MG (2003) Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14(11):2902\u20132907","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"3763_CR34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s004670050542","volume":"12","author":"JM Sorof","year":"1998","unstructured":"Sorof JM, Hawkins EP, Brewer ED, Boydstun II, Kale AS, Powell DR (1998) Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 12(9):764\u2013768","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3763_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004310000495","volume":"159","author":"RO Von Vigier","year":"2000","unstructured":"Von Vigier RO, Zberg PM, Teuffel O, Bianchetti MG (2000) Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. Eur J Pediatr 159(8):590\u2013593","journal-title":"Eur J Pediatr"},{"issue":"4","key":"3763_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.107.108886","volume":"51","author":"DK Benjamin Jr","year":"2008","unstructured":"Benjamin DK Jr, Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS (2008) Pediatric antihypertensive trial failures: analysis of end points and dose range. Hypertension 51(4):834\u2013840","journal-title":"Hypertension"},{"issue":"3","key":"3763_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"3763_CR38","unstructured":"Food and Drug Administration Safety and Innovation Act, S. 3187\u20133 (2012)"},{"issue":"18","key":"3763_CR39","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.2012.3435","volume":"307","author":"AN Sachs","year":"2012","unstructured":"Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy MD (2012) Pediatric information in drug product labeling. JAMA 307(18):1914\u20131915","journal-title":"JAMA"},{"issue":"1","key":"3763_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2165\/00003088-199732010-00002","volume":"32","author":"YW Lam","year":"1997","unstructured":"Lam YW, Banerji S, Hatfield C, Talbert RL (1997) Principles of drug administration in renal insufficiency. Clin Pharmacokinet 32(1):30\u201357","journal-title":"Clin Pharmacokinet"},{"key":"3763_CR41","unstructured":"Food and Drug and Administration (2014) General clinical pharmacology considerations for pediatric studies for drugs and biological products: guidance for industry (draft). In: Research CfDEa, ed. Food and Drug Administration: US Department of Health and Human Services"},{"issue":"6","key":"3763_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.jhh.1001203","volume":"15","author":"RO Von Vigier","year":"2001","unstructured":"Von Vigier RO, Franscini LM, Bianda ND, Pfister R, Casaulta Aebischer C, Bianchetti MG (2001) Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. J Hum Hypertens 15(6):387\u2013391","journal-title":"J Hum Hypertens"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3763-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T20:05:17Z","timestamp":1659297917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3763-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3763"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3763-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]},"assertion":[{"value":"3 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All trials were approved by the institutional review boards of the participating sites. Because the datasets obtained from DARRTS and the EDR contained no patient identifiers, we received a waiver of review from the Duke University Medical Center Institutional Review Board and a letter of exempt status from the FDA Research Involving Human Subjects Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was funded by a grant from the Duke University O\u2019Brien Center for Kidney Research, which is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and by the Duke University School of Medicine and Department of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The work of KMW was supported under an Intergovernmental Personnel Agreement (IPA) between the US Food and Drug Administration and Duke University.KMW receives support from the National Institute of Child Health and Human Development (NICHD) (1K23HD075891, 5K12HD047349) and the Thrasher Research Fund for his work in pediatric clinical pharmacology. DKB Jr receives support from the National Institutes of Health (NIH) (award 2K24HD058735\u201306, National Center for Advancing Translational Sciences (NCATS)award UL1TR001117, NICHD contract HSN275201000003I, and National Institute of Allergy and Infectious Diseases [NIAID] contract HHSN272201500006I); he also receives research support from Cempra Pharmaceuticals (subaward to HHSO100201300009C) and industry for neonatal and pediatric drug development (). PBS receives salary support for research from the NIH and the NCATS of the NIH (UL1TR001117), the NICHD (HHSN275201000003I and 1R01-HD081044\u201301), and the Food and Drug Administration (FDA) (1R18-FD005292\u201301); he also receives research support from Cempra Pharmaceuticals (subaward to HHS0100201300009C) and industry for neonatal and pediatric drug development (). The remaining authors have no disclosures. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}